Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | September 22, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date September 22, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,775 |
Reported balance
After 2026-09-22 transaction · row 1
1 source rowRow 1 · 2026-09-22 · Exercise / conversion · Acquired 895 · Balance 5,775 F1: On September 22, 2026, the Reporting Person exercised a portion of his stock option awarded on December 23, 2019 to purchase 1,000 shares of the Issuer's common stock at a price of $40.15 per share using the net settle method. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $40.15 · Expires 2029-12-23 | Direct | 2,000 |
Reported balance
After 2026-09-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-22 · Exercise / conversion · Disposed 1,000 · Balance 2,000 F1: On September 22, 2026, the Reporting Person exercised a portion of his stock option awarded on December 23, 2019 to purchase 1,000 shares of the Issuer's common stock at a price of $40.15 per share using the net settle method. |
| Common StockSEC Table I · non-derivative | IndirectHeld in Custody Account for Child | 133 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 133 |
| Common StockSEC Table I · non-derivative | IndirectHeld in Children's Trust | 267 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 267 |
Filing footnotes · ownership attribution and instrument terms
F1: On September 22, 2026, the Reporting Person exercised a portion of his stock option awarded on December 23, 2019 to purchase 1,000 shares of the Issuer's common stock at a price of $40.15 per share using the net settle method.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2025 Filed Jan 14, 2025 22:13 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 800 | $155.24 | $124,192.00 |
DisclosureSEC source: 0001415889-25-001444 · form4-01142025_100102.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,177 F2 · shares: On January 10, 2025, the Reporting Person sold 800 shares of the Issuer's common stock on the open market at an average price of $155.24 per share. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:13 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 7,385 | $41.19 | $304,188.15 |
DisclosureSEC source: 0001415889-25-001444 · form4-01142025_100102.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 10, 2025, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| December 24, 2024 Filed Dec 27, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030201 · form4-12272024_041201.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,592 F2 · shares: On December 24, 2024, the Reporting Person donated 200 shares of the Issuer's common stock to each of his three children, totaling 600 shares. Read SEC document |
| December 24, 2024 Filed Dec 27, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030201 · form4-12272024_041201.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,192 F1 · shares: On December 24, 2024, Mr. Getsinger transferred 1400 shares of the Issuer's common stock to a donor advised fund managed by Martha's Vineyard Investment Advisors. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029468 · form4-12162024_041205.xml · derivative · entry 7 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029468 · form4-12162024_041205.xml · derivative · entry 6 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,638 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029468 · form4-12162024_041205.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029468 · form4-12162024_041205.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029468 · form4-12162024_041205.xml · derivative · entry 5 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,388 Underlying: Common Stock · 388 shares Expires not disclosed F3 · derivative.exercise_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. F3 · derivative.expiration_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 21:45 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-025921 · form4-11012024_091150.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 F1 · shares: On October 31, 2024, Mr. Getsinger transferred 1000 shares of the Issuer's common stock to a donor advised fund managed by Martha's Vineyard Investment Advisors. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,405 | $78.36 | $110,095.80 |
DisclosureSEC source: 0001415889-24-020158 · form4-07262024_040708.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 F1 · shares: On July 24, 2024, the Reporting Person sold 1,405 shares of the Issuer's common stock on the open market at an average price of $78.36 per share. Read SEC document |
| July 19, 2024 Filed Jul 23, 2024 22:01 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001415889-24-019966 · form4-07232024_100730.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,500 Underlying: Common Stock · 4,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 19, 2024, the Reporting Person exercised a portion of his stock option awarded on January 7, 2016 to purchase 4,000 shares of the Issuer's common stock at a price of $30.44 per share, by using the net settle method. Read SEC document |
| July 19, 2024 Filed Jul 23, 2024 22:01 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,405 | $30.44 | $73,208.20 |
DisclosureSEC source: 0001415889-24-019966 · form4-07232024_100730.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 19, 2024, the Reporting Person exercised a portion of his stock option awarded on January 7, 2016 to purchase 4,000 shares of the Issuer's common stock at a price of $30.44 per share, by using the net settle method. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016617 · form4-12182023_101225.xml · derivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,500 shares Expires 2026-12-14 F2 · shares: On December 14, 2023, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 2,500 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 12/14/2024. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001415889-23-016617 · form4-12182023_101225.xml · derivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,500 Underlying: Common Stock · 1,500 shares Expires 2033-12-14 F1 · shares: On December 14, 2023, the Reporting Person received 10-year options to purchase 1,500 shares of the Issuer's common stock with an exercise price of $43.70 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2024. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012851 · form4-12202022_041240.xml · derivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025. F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting P erson includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012851 · form4-12202022_041240.xml · derivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; F3 · balance_after: (g) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (h) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006028 · form4-12162021_041221.xml · derivative · entry 5 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006028 · form4-12162021_041221.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and F3 · balance_after: (g) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:20 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136307 · tm2038593d7_4seq1.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock at an exercise price of $45.75. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and F3 · balance_after: (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| April 17, 2020 Filed Apr 20, 2020 21:04 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 1,000 | $35.10 | $35,100.00 |
DisclosureSEC source: 0001104659-20-048745 · a4.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:09 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001104659-19-075964 · a4.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; and (e) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning on 12/23/2020 and Expiration Date of 12/23/2029. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 21:06 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001104659-18-073085 · a4.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (d) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 21:11 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001104659-18-002380 · a4.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; and (c) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. Read SEC document |
| April 26, 2017 Filed Apr 27, 2017 20:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,500 | $67.74 | $101,604.90 |
DisclosureSEC source: 0001104659-17-026980 · a4.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F2 · shares: On April 26, 2017, the Reporting Person sold 1,500 shares of the Issuer's common stock on the open market at an average price of $67.7366 per share. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 20:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,500 | $67.69 | $101,541.75 |
DisclosureSEC source: 0001104659-17-026980 · a4.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: On April 25, 2017, the Reporting Person sold 1,500 shares of the Issuer's common stock on the open market at an average price of $67.6945 per share. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 21:07 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 5,000 | $31.82 Strike: $31.82 | $159,100.00 |
DisclosureSEC source: 0001104659-17-002796 · a4.xml · derivative · entry 5 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 5,000 shares Expires 2024-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 13, 2017, the Reporting Person sold 5,000 shares of common stock on the open market at a price of $70.5772 per share. F3 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase 7,000 shares of common stock at the price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 21:07 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $70.58 | $352,886.00 |
DisclosureSEC source: 0001104659-17-002796 · a4.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F2 · shares: On January 13, 2017, the Reporting Person sold 5,000 shares of common stock on the open market at a price of $70.5772 per share. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 21:07 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,000 | $31.82 | $159,100.00 |
DisclosureSEC source: 0001104659-17-002796 · a4.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 13, 2017, the Reporting Person exercised his stock option received on December 11, 2014 to purchase 5,000 shares of the Issuer's common stock at a price of $31.82 per share. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:23 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 3,000 | $30.44 Strike: $30.44 | $91,320.00 |
DisclosureSEC source: 0001104659-17-002323 · a4.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 3,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 11, 2017, the Reporting Person exercised his stock option received on January 7, 2016 to purchase 3,000 shares of the Issuer's common stock at a price of $30.44 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase a total of 12,000 shares of the Issuer's common stock, which include options to purchase 5,000 shares of common stock at the price of $31.82 per share with the date exercisable of 12/11/2015 and expiration date of 12/11/2024 and options to purchase 7,000 shares of common stock at the price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:23 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 3,000 | $30.44 | $91,320.00 |
DisclosureSEC source: 0001104659-17-002323 · a4.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 11, 2017, the Reporting Person exercised his stock option received on January 7, 2016 to purchase 3,000 shares of the Issuer's common stock at a price of $30.44 per share. Read SEC document |
| January 05, 2017 Filed Feb 24, 2017 23:08 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $71.75 | $0.00 |
DisclosureSEC source: 0001104659-17-011658 · a4.xml · derivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 F1 · shares: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; and (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027. Read SEC document |
| October 12, 2016 Filed Oct 13, 2016 20:05 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,935 | $57.71 | $111,675.82 |
DisclosureSEC source: 0001104659-16-150065 · a4.xml · nonDerivative · entry 1 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F1 · shares: On October 12, 2016, the Reporting Person sold 1,935 shares of the Issuer's common stock at a price of $57.7136 per share on the open market. Read SEC document |
| October 04, 2016 Filed Oct 7, 2016 01:47 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 400 | $58.17 | $23,268.00 |
DisclosureSEC source: 0001104659-16-149169 · a4.xml · nonDerivative · entry 3 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By inherited IRA. Disclosed balance after: 0 F2 · shares: On October 4, 2016, the Reporting Person sold 400 shares of the Issuer's common stock held through the Peter W Getsinger inherited IRA at a price of $58.17 per share on the open market. Read SEC document |
| October 04, 2016 Filed Oct 7, 2016 01:47 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 500 | $58.21 | $29,105.60 |
DisclosureSEC source: 0001104659-16-149169 · a4.xml · nonDerivative · entry 2 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA. Disclosed balance after: 0 F1 · shares: On October 4, 2016, the Reporting Person sold 500 shares of the Issuer's common stock held through the Peter W Getsinger IRA at a price of $58.21128 per share on the open market. Read SEC document |
| June 27, 2016 Filed Oct 7, 2016 01:47 UTC | ARGAN INC AGX · Entity 3828 | OtherCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-149169 · a4.xml · nonDerivative · entry 5 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in custody account for child. Disclosed balance after: 133 F3 · shares: On June 27, 2016, 33 shares of the Issuer's common stock were transferred by the Reporting Person's account held by Trust for children to the account held in custody account for child. Read SEC document |
| June 27, 2016 Filed Oct 7, 2016 01:47 UTC | ARGAN INC AGX · Entity 3828 | OtherCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-149169 · a4.xml · nonDerivative · entry 4 Getsinger Peter W · CIK 0001627519 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for children. Disclosed balance after: 267 F3 · shares: On June 27, 2016, 33 shares of the Issuer's common stock were transferred by the Reporting Person's account held by Trust for children to the account held in custody account for child. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.